Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 12410 | 844 | 40.6 | 86% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 2911 | 2271 | UROTENSIN II//NEUROPEPTIDE FF//NEUROPEPTIDE S |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | NEUROPEPTIDE FF | Author keyword | 354 | 93% | 16% | 133 |
| 2 | PROLACTIN RELEASING PEPTIDE | Author keyword | 97 | 82% | 7% | 56 |
| 3 | NEUROPEPTIDE FF NPFF | Author keyword | 52 | 100% | 2% | 18 |
| 4 | GONADOTROPIN INHIBITORY HORMONE GNIH | Author keyword | 49 | 94% | 2% | 17 |
| 5 | PRRP | Author keyword | 48 | 91% | 2% | 20 |
| 6 | NPFF | Author keyword | 44 | 77% | 4% | 30 |
| 7 | RFAMIDE RELATED PEPTIDE | Author keyword | 38 | 89% | 2% | 17 |
| 8 | RF9 | Author keyword | 30 | 100% | 1% | 12 |
| 9 | RFAMIDE PEPTIDE | Author keyword | 30 | 100% | 1% | 12 |
| 10 | PROLACTIN RELEASING PEPTIDE PRRP | Author keyword | 23 | 100% | 1% | 10 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | NEUROPEPTIDE FF | 354 | 93% | 16% | 133 | Search NEUROPEPTIDE+FF | Search NEUROPEPTIDE+FF |
| 2 | PROLACTIN RELEASING PEPTIDE | 97 | 82% | 7% | 56 | Search PROLACTIN+RELEASING+PEPTIDE | Search PROLACTIN+RELEASING+PEPTIDE |
| 3 | NEUROPEPTIDE FF NPFF | 52 | 100% | 2% | 18 | Search NEUROPEPTIDE+FF+NPFF | Search NEUROPEPTIDE+FF+NPFF |
| 4 | GONADOTROPIN INHIBITORY HORMONE GNIH | 49 | 94% | 2% | 17 | Search GONADOTROPIN+INHIBITORY+HORMONE+GNIH | Search GONADOTROPIN+INHIBITORY+HORMONE+GNIH |
| 5 | PRRP | 48 | 91% | 2% | 20 | Search PRRP | Search PRRP |
| 6 | NPFF | 44 | 77% | 4% | 30 | Search NPFF | Search NPFF |
| 7 | RFAMIDE RELATED PEPTIDE | 38 | 89% | 2% | 17 | Search RFAMIDE+RELATED+PEPTIDE | Search RFAMIDE+RELATED+PEPTIDE |
| 8 | RF9 | 30 | 100% | 1% | 12 | Search RF9 | Search RF9 |
| 9 | RFAMIDE PEPTIDE | 30 | 100% | 1% | 12 | Search RFAMIDE+PEPTIDE | Search RFAMIDE+PEPTIDE |
| 10 | PROLACTIN RELEASING PEPTIDE PRRP | 23 | 100% | 1% | 10 | Search PROLACTIN+RELEASING+PEPTIDE+PRRP | Search PROLACTIN+RELEASING+PEPTIDE+PRRP |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | FLFQPQRFAMIDE | 233 | 97% | 8% | 66 |
| 2 | MAMMALIAN NEUROPEPTIDE | 197 | 98% | 6% | 50 |
| 3 | MORPHINE MODULATING PEPTIDE | 167 | 95% | 7% | 56 |
| 4 | HYPOPHYSIOTROPIC ROLE | 159 | 94% | 7% | 58 |
| 5 | LPXRF AMIDE PEPTIDES | 121 | 97% | 4% | 34 |
| 6 | MORPHINE MODULATING PEPTIDES | 121 | 97% | 4% | 34 |
| 7 | PRRP | 94 | 97% | 3% | 28 |
| 8 | HYPOTHALAMIC NEUROPEPTIDE | 90 | 77% | 7% | 62 |
| 9 | FMRF NH2 LIKE PEPTIDE | 68 | 100% | 3% | 22 |
| 10 | RFAMIDE RELATED PEPTIDE 3 | 60 | 68% | 6% | 53 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Review: regulatory mechanisms of gonadotropin-inhibitory hormone (GnIH) synthesis and release in photoperiodic animals | 2013 | 15 | 110 | 72% |
| Review: evolution of GnIH and related peptides structure and function in the chordates | 2014 | 3 | 71 | 83% |
| Neuropeptide FF, a mammalian neuropeptide with multiple functions | 1996 | 148 | 75 | 77% |
| Gonadotropin-inhibitory hormone (GnIH), GnIH receptor and cell signaling | 2013 | 11 | 71 | 79% |
| Recent advances in mammalian RFamide peptides: The discovery and functional analyses of PrRP, RFRPs and QRFP | 2006 | 89 | 117 | 77% |
| Gonadotropin-inhibitory hormone (GnIH): Discovery, progress and prospect | 2012 | 27 | 102 | 74% |
| 26Rfa/GPR103 | 2014 | 2 | 51 | 90% |
| Breakthrough in neuroendocrinology by discovering novel neuropeptides and neurosteroids: 1. Discovery of gonadotropin-inhibitory hormone (GnIH) across vertebrates | 2014 | 2 | 63 | 89% |
| Discovery and Evolutionary History of Gonadotrophin-Inhibitory Hormone and Kisspeptin: New Key Neuropeptides Controlling Reproduction | 2010 | 60 | 104 | 52% |
| Gonadotropin-inhibitory hormone (GnIH) and its control of central and peripheral reproductive function | 2010 | 48 | 105 | 61% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | INTEGRAT BRAIN SCISHINJUKU KU | 15 | 77% | 1.2% | 10 |
| 2 | INTEGRAT BRAIN SCI | 8 | 19% | 4.3% | 36 |
| 3 | MED LIFE SCISHINJUKU KU | 5 | 60% | 0.7% | 6 |
| 4 | HERITAGE MED 530 | 4 | 50% | 0.7% | 6 |
| 5 | DISCOVERY S 1 | 4 | 18% | 2.1% | 18 |
| 6 | REPROD NEUROENDOCRINOL | 3 | 29% | 1.1% | 9 |
| 7 | INNOVAT BIOMEDINSERM U982 | 2 | 67% | 0.2% | 2 |
| 8 | PHYSIOPHARMACOL DOULEUR | 2 | 67% | 0.2% | 2 |
| 9 | RIA MED CHEM | 2 | 67% | 0.2% | 2 |
| 10 | UNDER BIOCHEM HONORS PROGRAM | 2 | 67% | 0.2% | 2 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000140625 | KISSPEPTIN//GPR54//KISS 1 |
| 2 | 0.0000078902 | TERMINAL NERVE//NERVUS TERMINALIS//GONADOTROPIN RELEASING HORMONE |
| 3 | 0.0000060601 | NEUROMEDIN U//NEUROPEPTIDE W//NEUROMEDIN S |
| 4 | 0.0000054395 | PHOTOREFRACTORINESS//BUNTING//BROODINESS |
| 5 | 0.0000045962 | MYXINIDAE//PARAMYXINE//HAGFISH |
| 6 | 0.0000044604 | LYMNAEA//PROCEREBRUM//LYMNAEA STAGNALIS |
| 7 | 0.0000042137 | SALUSIN//SALUSIN BETA//SALUSIN ALPHA |
| 8 | 0.0000042114 | ACID SENSING ION CHANNEL//ACID SENSING ION CHANNELS//ASIC3 |
| 9 | 0.0000041537 | TYR MIF 1//MIF 1//BLOOD BRAIN BARRIER GRP |
| 10 | 0.0000040026 | SOCIAL SEPARATION STRESS//ADV ANIM MARINE BIO OURCES//REGULAT METAB BEHAV |